Are you interested in elemental analysis solutions? Sign up for this webinar series from Thermo Fisher Scientific, on their cutting-edge ICP-MS and ICP-OES solutions. The seminar on the 16th of October, is hosted at Capitainer and in our microsampling laboratory miQro Lab Solutions, Rhode Island, USA. The laboratory is led by our principle sccientist Donald Chace who is the director of the lab. If you want to learn more about microsampling with Capitainer for elemental analysis and what services that can be offered at miQro, equiped with Thermo Fishers ICP-MS solution, please reach out to us via [email protected]. #icpms #exposome #microsampling #ElementalAnalysis #environmentalmonitoring
Capitainer AB
Medicinsk utrustning
Convenient and quantitative blood sampling at the fingertip for everyone, everywhere at anytime.
Om oss
Capitainer started in 2016 and is a new technique where patients take blood samples on their own at home. The technology, which is more accurate than today’s solutions, allows patients to leave blood for analysis from home. Capitainer offers environmental as well as cost savings for healthcare that manages millions of conventional blood samples annually.
- Webbplats
-
https://capitainer.com/
Extern länk för Capitainer AB
- Bransch
- Medicinsk utrustning
- Företagsstorlek
- 11–50 anställda
- Huvudkontor
- Solna
- Typ
- Publikt aktiebolag
- Grundat
- 2016
- Specialistområden
- Technology, medical devices, near patient sampling, Dry Blood Spot, Innovation, Self Sampling, Home Sampling och Microsampling
Adresser
-
Primär
Solna Torg 19
Solna, 171 45, SE
Anställda på Capitainer AB
Uppdateringar
-
What does the future of Alzheimer’s disease diagnostics look like? Professor Henrik Zetterberg shares his perspectives and research on developing next-generation diagnostics for Alzheimer’s, article: https://lnkd.in/dYtUaCeq In the clip, Professor Zetterberg discusses quantitative dried plasma microsampling technology - with only a few drops of dried blood from a finger prick, it’s possible to measure all key blood biomarkers for Alzheimer’s disease, by using ultra-sensitive multiplex technology NULISA (Alamar Biosciences, Inc.). These dried blood samples provide results that align with traditional venous blood draws. These biomarkers are stable in room temperature for up to six months. This opens the door to democratizing Alzheimer’s diagnostics by enabling remote testing, even in areas far from labs. Professor Zetterberg and his team has used Capitainer®B50 and been one of the first users, pre-launch, of our new device Capitainer®SEP10.
-
Dried blood microsampling has vast application areas and provides a fantastic opportunity for more person-centric sampling solutions. However, the composition of whole blood is highly complex, which limits the use of whole blood samples since some clinical laboratory analyses requires the separation of the cell fraction. For quantitative analysis of certain analytes, e.g., potassium, plasma is the only suitable sampling matrix since sampling in whole blood does not yield reliable results. Plasma is also used to monitor the concentrations of experimental drugs and their metabolites during clinical trials for new candidate drugs, since it harbours the drug fraction most relevant for studying the pharmacokinetic and pharmacodynamic effects of the experimental drug. In this article, we describe the needs and also several requirements that must be met to make microsampling of separated blood available. Read the post and stay tuned with Capitainer for more news about microsampling for a separated blood matrix. #microsampling #HealthTechInnoation https://lnkd.in/dtKxyPay
-
Decentralised clinical trials gained momentum during the COVID-19 pandemic, and their prevalence continues to grow rapidly. In contrast to centralised or conventional clinical trials, which require study participants to take part ’in person’, decentralised clinical trials allow remote participation using state-of-the-art digital health technologies. In this article, we compare centralised and decentralised clinical trials, briefly overview how decentralised trials are performed, and outline their advantages over conventional trials. Reach out to us and talk to the Capitainer team of sampling and application specialists, to learn how our sampling solution can help to make your study better. #clinicaltrial #microsampling #decentralizedclinicaltrials #patientcentricity #decentralizedtrials https://lnkd.in/dhW297wV
Decentralised clinical trials, an introduction - Capitainer
https://capitainer.com
-
Capitainer AB omdelade detta
A method for PFAS testing with Capitainer has been developed. The European Environment Agency state in the report “Risks of PFAS for human health in Europe” from 2024 that “Future human biomonitoring will be essential to track long-term trends of previously- and currently-used chemicals like PFAS”. As a background, the report states that “Teenagers in Europe face health risks from exposure to toxic per- and polyfluoroalkyl substances (PFAS) according to a series of studies conducted between 2014 and 2021. Of the teenagers who participated in the studies, an average of 14.3% had blood levels above the health-based guidance value (HBGV), with two countries exceeding 20%.” In a recent publication from University of Turin, the researchers developed a method to test blood levels of PFAS from microsamples collected with Capitainer. The developed method can detect and quantify 25 different PFAS from only 10µL of dried blood. This development enables efficient and easy testing programs with at-home sampling, that perfectly could meet the needs of biomonitoring stated in the report from the European Environmental Agency. Thank you Martina Galletto and Alberto Salomone, for excellent development work. Their paper is available in the link below. Contact us at Capitainer if you want to learn more about human biomonitoring using our sampling solution. #exposome #PFAS #microsampling Link to the report from the European Environment Agency is available here: https://lnkd.in/dXx4tpRn https://lnkd.in/dxb6ZhWc
Development and validation of the UHPLC-MS/MS method for the quantitative determination of 25 PFAS in dried blood spots - Analytical and Bioanalytical Chemistry
link.springer.com
-
A method for PFAS testing with Capitainer has been developed. The European Environment Agency state in the report “Risks of PFAS for human health in Europe” from 2024 that “Future human biomonitoring will be essential to track long-term trends of previously- and currently-used chemicals like PFAS”. As a background, the report states that “Teenagers in Europe face health risks from exposure to toxic per- and polyfluoroalkyl substances (PFAS) according to a series of studies conducted between 2014 and 2021. Of the teenagers who participated in the studies, an average of 14.3% had blood levels above the health-based guidance value (HBGV), with two countries exceeding 20%.” In a recent publication from University of Turin, the researchers developed a method to test blood levels of PFAS from microsamples collected with Capitainer. The developed method can detect and quantify 25 different PFAS from only 10µL of dried blood. This development enables efficient and easy testing programs with at-home sampling, that perfectly could meet the needs of biomonitoring stated in the report from the European Environmental Agency. Thank you Martina Galletto and Alberto Salomone, for excellent development work. Their paper is available in the link below. Contact us at Capitainer if you want to learn more about human biomonitoring using our sampling solution. #exposome #PFAS #microsampling Link to the report from the European Environment Agency is available here: https://lnkd.in/dXx4tpRn https://lnkd.in/dxb6ZhWc
Development and validation of the UHPLC-MS/MS method for the quantitative determination of 25 PFAS in dried blood spots - Analytical and Bioanalytical Chemistry
link.springer.com
-
📬 The latest edition of Capitainer's newsletter is here, packed with exciting updates! As we wrap up the summer of 2024, we're thrilled to share our latest developments in healthcare innovation and diagnostics. From a strategic partnership to expand access in Africa, to our involvement in groundbreaking studies on precision nutrition, this issue highlights our commitment to making a global impact. Plus, dive into the future of diagnostics with insights on multiplex proteomics and see where you can meet us next! Don't miss out – subscribe to our newsletter and stay at the forefront of healthcare innovation: https://lnkd.in/duCFj87h #Capitainer #HealthcareInnovation #Microsampling
Capitainer Update: Driving Innovation in Global Health and Diagnostics
Capitainer AB på LinkedIn
-
Capitainer AB omdelade detta
Thank you Health2B Norway and Eirik Løvbakken for arranging today’s seminar on "Innovative sampling solutions" and for giving us at Capitainer the chance to present our solutions and clinical projects under the title “Person-centered blood sampling at-home”. A special thank you also to Nils Tore Vethe, head of Clinical pharmacology at Rikshospitalet University Hospital, for presenting your work to offer monitoring diagnostics for kidney transplant recipients via microsampling. Your presentation provided valuable insights to the audience about work performed with Capitainer sampling. A special thank you also to the interested and active audience that gave the seminar a fantastic discussion session, perfectly moderated by Andreas Matussek, on opportunities and challenges with implementing new sampling routines closer to the patients. Health2B is an arena for public-private health collaboration in Forskningsparken - Oslo Science Park. #futurehealth #healthtech #microsampling
-
Thank you Health2B Norway and Eirik Løvbakken for arranging today’s seminar on "Innovative sampling solutions" and for giving us at Capitainer the chance to present our solutions and clinical projects under the title “Person-centered blood sampling at-home”. A special thank you also to Nils Tore Vethe, head of Clinical pharmacology at Rikshospitalet University Hospital, for presenting your work to offer monitoring diagnostics for kidney transplant recipients via microsampling. Your presentation provided valuable insights to the audience about work performed with Capitainer sampling. A special thank you also to the interested and active audience that gave the seminar a fantastic discussion session, perfectly moderated by Andreas Matussek, on opportunities and challenges with implementing new sampling routines closer to the patients. Health2B is an arena for public-private health collaboration in Forskningsparken - Oslo Science Park. #futurehealth #healthtech #microsampling
-
Our latest blog post is a publication highlight describing a research study using Capitainer based self-sampling for multiplex proteomics analysis. Capitainer sampling kits were sent out to 2000 randomized consenting adults who collected samples in their own homes. Multiplexed analysis was performed using a 276 plex PEA assay approach from Olink Proteomics. In addition, a multi-analyte serology approach was applied using MagPlex, from Luminex . The study, conducted at SciLifeLab and lead by Claudia Fredolini and Jochen Schwenk, demonstrates the power of at-home sampling approaches and the compatibility of Capitainer samples with state of the art analytical platforms. We hope our post and the publication can inspire other researchers to new pioneering studies. At Capitainer, our specialists are available to support you in conducting your microsampling based studies. #microsampling #lifesciences #proteomics https://lnkd.in/dkmGJEvd
Publication highlight: Swedish study demonstrates compatibility of Capitainer self-sampling with Olink’s proteomics for large-scale health studies - Capitainer
https://capitainer.com
Liknande sidor
Finansiering
Senaste finansieringsrunda
Serie A1 435 165,00 US$